Aurobindo Pharma to Buy Solar Power From Open Access Projects in Telangana

The company will invest ₹107.6 million to acquire 26% capital shares in two open access power projects

February 24, 2021

/ Harsh Shukla

/ Finance and M&A, Solar

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights

Save

Aurobindo Pharma, a Hyderabad-based pharmaceutical company, will procure solar power from two 15 MW group captive projects of NVNR Power and Infra in Hyderabad, Telangana.

ℹ️ This article is free for registered users. Sign in to continue reading.

Sign In to Continue Reading

Create a free account to access the full article and exclusive features from Mercom India's renewable energy coverage.

✓Access to free articles and news

✓Save articles for later reading

✓Personalized content recommendations

✓Newsletter subscriptions

Sign Up FreeLog In

Harsh Shukla

More articles from Harsh Shukla.

Aurobindo PharmainvestmentNVNRPowerSolar

PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

SIGN UP

RECENT POSTS